The cobas® Liat System is the only FDA cleared molecular diagnostic platform to offer real- time PCR results in 20 minutes or less Utilizing Nobel prize winning polymerase chain reaction (PCR) ...
Designed for use in doctor’s offices, clinics and emergency rooms, the PCR diagnostic aims to deliver results in fewer than ...
Medical Device Network on MSN
Roche’s test for Bordetella infections gains FDA clearance
The test, which runs on the cobas liat system, is said to deliver results in 15 minutes.
The FINANCIAL — Roche on September 22 announced that the U.S. Food and Drug Administration (FDA) has granted CLIA (Clinical Laboratory Improvement Amendments) waiver for the cobas Influenza A/B test ...
Roche Receives FDA Clearance With CLIA Waiver And CE Mark For Its First Point-Of-Care Test For Diagnosing Bordetella Infections, Including Whooping Cough (Pertussis). <li /> The point-of-care test ...
A newly cleared point-of-care test will enable rapid identification of whooping cough, according to a press release from ...
The US Food and Drug Administration (FDA) has cleared the cobas Influenza A/B test for use on the cobas Liat System, according to manufacturer Roche. It is the first Clinical Laboratory Improvement ...
cobas 5800 is a new compact addition to the Roche molecular diagnostics portfolio that provides a scalable, high performance testing solution for labs of all sizes. Infectious diseases, such as HIV, ...
PLEASANTON, Calif., Feb. 23, 2022 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the expansion of the COVID-19 PCR portfolio to the cobas Ⓡ 5800 System, a recently launched ...
Though the demand for COVID-19 testing is beginning to wind down, Roche is looking to make the most of what’s left, with a new molecular test designed to help healthcare workers track the pandemic ...
ಕೆಲವು ಫಲಿತಾಂಶಗಳನ್ನು ಮರೆಮಾಡಲಾಗಿದೆ ಏಕೆಂದರೆ ನೀವು ಅವುಗಳನ್ನು ಪ್ರವೇಶಿಸಲು ಸಾಧ್ಯವಾಗದಿರಬಹುದು.
ಪ್ರವೇಶಿಸಲಾಗದ ಫಲಿತಾಂಶಗಳನ್ನು ತೋರಿಸಿ
ಪ್ರತಿಕ್ರಿಯೆ